Breaking news: Today, Alkermes was named as a Best Large Workplace in BioPharma? by Fortune Magazine! We are honored to receive this recognition, which is based on the results of a survey of #TeamAlkermes employees. Learn more about what makes Alkermes an employer of choice in the biotech space by checking out the article: https://lnkd.in/eU6ydQ5M
Alkermes
生物技术研究
Alkermes is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience.
关于我们
At Alkermes, we apply our deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders. Our patient-inspired science, integrated research strategy, sophisticated development capabilities and specialized commercial infrastructure enable us to pursue the development and commercialization of innovative new medicines, including those for people with conditions that have traditionally been overlooked or stigmatized. Our greatest strengths at Alkermes are our people and our inherent empathy for patients, families and caregivers. Neurological and psychiatric disorders strike people at the core of who they are and impact many facets of their lives. We work with urgency to develop new treatment options for people living with these conditions. Beyond our important mission of developing medicines, we believe it is our responsibility to take a holistic approach as we seek to support patients, caregivers and broader impacted communities. We remain committed to patient engagement, responsible and sustainable operations, and equitable access to quality treatment. Headquartered in Ireland, Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio. See our Community Guidelines: https://www.alkermes.com/social-community-guidelines
- 网站
-
https://www.alkermes.com/
Alkermes的外部链接
- 所属行业
- 生物技术研究
- 规模
- 1,001-5,000 人
- 总部
- Dublin
- 类型
- 上市公司
- 创立
- 1987
- 领域
- Pharma、Pharmaceutical、Sales、Marketing、IT、CNS、Addiction、Information technology、Human Resources、Sales、District Sales、Regional Sales、Research & Development、R&D、Manufacturing、Medical Affairs、serious mental illness、biotech、addiction、narcolepsy、neuroscience、sleep disorders和biotech
地点
Alkermes员工
动态
-
Millions of Americans live with a mental health condition, meaning neighbors, coworkers, mere acquaintances or close loved ones may be dealing with a serious #mentalillness. When it comes to discussing mental health, there’s no one-size-fits-all approach. If you want to feel more confident in supporting someone who may be struggling, NAMI offers thoughtful guidance on starting these conversations, what to say (and what to avoid), and how to offer meaningful support. https://lnkd.in/guWhmdJb Source: NAMI
-
-
Yesterday, #TeamAlkermes put on their green for a St. Patrick’s Day celebration breakfast. Thanks to all who attended!
-
-
#SleepAwarenessWeek may be coming to an end, but our commitment to people living with sleep disorders continues! Visit our website to learn more about #narcolepsy and #idiopathichypersomnia. https://lnkd.in/g3nfQZMM
-
Today, #TeamAlkermes joins World Sleep Society and the global sleep community in celebrating #WorldSleepDay. While sleep health is a priority for all, Julie Lekstrom Himes, our SVP of Clinical Development, shines a light on the unique experiences of people living with idiopathic hypersomnia. https://lnkd.in/ga-uP4pf #ThisisIH
-
-
Did you know that March 11-17 is #BrainAwarenessWeek? On #TeamAlkermes, we are driven by our purpose and values to make a difference in the lives of people living with complex neurological conditions. Visit our website to learn more: www.alkermes.com
-
Did you know there’s a difference between binge drinking and high-intensity drinking? Binge drinking is defined as five or more drinks for men and four or more for women in the span of two hours. But high-intensity drinking doubles those numbers to 10 or more standard drinks for men and eight for women. Understanding different drinking patterns may be important for recognizing the impact on your own health. This resource from NIAAA breaks down the nuances of alcohol consumption and its effects. https://lnkd.in/eM_KTMZJ Source: NIAAA This post does not constitute or imply endorsement of Alkermes by the U.S. Government, including the NIAAA.
-
-
Every March, #BrainAwarenessWeek highlights the importance of brain science and its impact on our communities. For those who have loved ones living with a psychiatric disorder, this observance may carry even greater significance. Supporting brain science isn’t just about research—it’s also about showing up for those who may benefit from it. If you have a family member with #schizophrenia, #bipolardisorder, or another serious #mentalillness, the American Psychological Association offers valuable tips on encouraging them to seek help and providing meaningful support. https://lnkd.in/eZd-u4FK Source:? American Psychological Association
-
Recognizing the signs of #AlcoholUseDisorder isn’t always straightforward. While risky drinking behavior can be a cause of concern, knowing if you have an alcohol use disorder can be harder to determine. That’s why understanding what signs to look out for may be useful. NIAAA’s Rethinking Drinking resource provides detailed questions to ask yourself if you’re evaluating your relationship with alcohol.? https://lnkd.in/ebGDuBep Source: NIAAA This post does not constitute or imply endorsement of Alkermes by the U.S. Government, including the NIAAA.
-
-
During Sleep Awareness Week and year-round, #TeamAlkermes is committed to raising awareness about sleep health and the specific challenges faced by people living with sleep disorders such as #narcolepsy and #idiopathichypersomnia. Hear more from our colleagues in this video. #SleepAwarenessWeek